Inflammasomes in Atherosclerosis and Atherothrombosis
Frontiers in Bioscience-Landmark · 20.10.2026 · 31 (10)
DOI: 10.31083/fbl49612 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 20.10.2026. Verfasst von Konstantinos Grigoriou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Medical School, University of Athens, 11527 Athens, Greece. Hauptthemen laut MEDLINE: Inflammasomes, Atherosclerosis, Thrombosis. Die Arbeit nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atherosclerotic cardiovascular disease and its thrombotic complications, particularly myocardial infarction and ischemic stroke, remain leading causes of morbidity and mortality worldwide. Atherosclerosis was historically considered primarily a lipid accumulation disorder; however, it is now well recognized as a chronic inflammatory disesse driven in large part by innate immune signaling. Inflammasomes, particularly NOD-like receptor protein 3 (NLRP3) and absent in melanoma 2 (AIM2), play important role in this process, linking vascular inflammation, plaque progression, and thrombosis through caspase-1 activation, interleukin-1 beta (IL-1β) and IL-18 release, and gasdermin-mediated pyroptosis. In this narrative review we integrate mechanistic and translational evidence defining inflammasome activity across the continuum of atherosclerosis and atherothrombosis. We highlight inflammasome signaling in endothelial cells, macrophages, vascular smooth muscle cells, platelets, neutrophils, and perivascular adipose tissue, and discuss how these pathways contribute to early inflammation, necrotic core expansion, fibrous cap destabilization, and ultimately to acute thrombus formation. Emerging data on AIM2 activation, clonal hematopoiesis, platelet inflammasomes, and cell-free deoxyribonucleic acid (DNA) further expand current paradigms beyond macrophage focused models on macrophages. We also review single-cell and spatial transcriptomics, circulating biomarkers, and advanced vascular imaging approaches that may enable the identification of inflammasome-high atherothrombotic phenotypes. Finally, we appraise therapeutic strategies targeting inflammasomes and downstream pathways. These include IL-1β and IL-6 inhibition, colchicine, direct NLRP3 inhibition, and cardiometabolic therapies with indirect effects on inflammasome activity. By examining the role of inflammasomes in linking plaque pathogenesis to thrombosis, this review outlines key translational opportunities and challenges for the precision prevention of atherothrombosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Medical School, University of Athens, 11527 Athens, Greece.
- Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
- Manchester Heart Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, M13 9WL Manchester, UK.
- First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, Harefield Hospital, UB9 6JH London, UK.
- Emergency Department, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
Zitieren
APA
Grigoriou, K., Antoniadis, A. P., Lamprou, V., Ktenopoulos, N., Theofilis, P., Iliakis, P., Vlachakis, P. K., Apostolos, A., Fyntanidou, B., Karagiannidis, E., Fragakis, N., & Karakasis, P. (2026). Inflammasomes in Atherosclerosis and Atherothrombosis. Frontiers in Bioscience-Landmark, 31(10). https://doi.org/10.31083/fbl49612
Vancouver
Grigoriou K, Antoniadis AP, Lamprou V, Ktenopoulos N, Theofilis P, Iliakis P, et al. Inflammasomes in Atherosclerosis and Atherothrombosis. Frontiers in Bioscience-Landmark. 2026;31(10). doi:10.31083/fbl49612
BibTeX
@article{Grigoriou2026,
author = {Grigoriou, Konstantinos and Antoniadis, Antonios P and Lamprou, Vasileios and Ktenopoulos, Nikolaos and Theofilis, Panagiotis and Iliakis, Panagiotis and Vlachakis, Panayotis K and Apostolos, Anastasios and Fyntanidou, Barbara and Karagiannidis, Efstratios and Fragakis, Nikolaos and Karakasis, Paschalis},
title = {Inflammasomes in Atherosclerosis and Atherothrombosis},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {10},
doi = {10.31083/fbl49612}
}
EUVIMED